AI-generated summary
The authors followed 17 people with rosacea-associated meibomian gland dysfunction for 12 months after four intense pulsed light sessions given three weeks apart. They report that lid margin vascularity, meibum quality and expressibility, and ocular symptoms improved and stayed improved, while tear break-up time, staining score and noninvasive tear break-up time improvements were not maintained at 6 and 12 months.
- Participants
- 17
- Who or what was studied
- Patients with rosacea-associated meibomian gland dysfunction (moderate to severe)
- Limits stated in the abstract
- The abstract describes a small single-group study with no control group, and the authors do not state that the treatment works beyond the parameters reported.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.